Taylor C R
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, 90033, USA.
Biotech Histochem. 2006 Jan-Feb;81(1):3-12. doi: 10.1080/10520290600667866.
Molecular morphology seeks to integrate the traditional morphologic criteria of surgical pathology with immunohistochemical and in situ hybridization techniques that allow demonstration of a variety of molecules, proteins, RNA and DNA in a tissue section. While immunohistochemistry has proven to be successful for demonstrating lineage related biomarkers of value for diagnosis and classification of tumors, concerns have been raised periodically about validation of reagents, overall reproducibility of the staining method, and interpretation of results. These concerns have been heightened by the burgeoning interest in prognostic markers, where the question extends beyond a relatively simple positive or negative result to an absolute need for quantification of the staining result; not only is it positive, but how much is there? In this presentation at the Annual Meeting of the Biological Stain Commission in June, 2005, I advocate a total test approach that requires systematic attention to pre-analytic, analytic, and post-analytic issues. The approach encompasses all aspects of test performance from specimen acquisition, through fixation, antigen retrieval, processing, staining, interpretation, and reporting of results. A similar systematic approach also may be adopted for in situ hybridization methods, which have performance requirements that in many ways parallel immunohistochemistry.
分子形态学旨在将外科病理学的传统形态学标准与免疫组织化学和原位杂交技术相结合,这些技术能够在组织切片中显示多种分子、蛋白质、RNA和DNA。虽然免疫组织化学已被证明在显示对肿瘤诊断和分类有价值的谱系相关生物标志物方面是成功的,但人们不时对试剂的验证、染色方法的整体可重复性以及结果的解释提出担忧。对预后标志物的兴趣迅速增长,使得这些担忧更加突出,在这种情况下,问题不仅涉及相对简单的阳性或阴性结果,还绝对需要对染色结果进行量化;不仅要知道它是阳性,还要知道有多少?在2005年6月生物染色委员会年会上的这次演讲中,我提倡一种全面测试方法,该方法要求系统关注分析前、分析中和分析后问题。该方法涵盖了从标本采集到结果报告的测试性能的各个方面,包括固定、抗原修复、处理、染色、结果解释等。原位杂交方法也可采用类似的系统方法,其性能要求在许多方面与免疫组织化学相似。